Bicycle Therapeutics PLC SEC filings BCYC
Bicycle Therapeutics PLC has 660 filings in SEC EDGAR's recent list, going back to Dec 21, 2018. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 20, 2026 | Aug 18, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Other events
|
May 21, 2026 | May 21, 2026 |
| 10-Q | Quarterly report | Apr 30, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 30, 2026 | Apr 30, 2026 |
| ARS | Annual report to shareholders | Apr 22, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 22, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Other events
|
Apr 20, 2026 | Apr 20, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2026 | Jun 17, 2026 |
| S-8 | Employee stock plan registration | Mar 17, 2026 | — |
| 10-K | Annual report | Mar 17, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 17, 2026 | Mar 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 3, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| S-8 | Employee stock plan registration | Oct 30, 2025 | — |
| 10-Q | Quarterly report | Oct 30, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 8, 2025 | Sep 8, 2025 |
| EFFECT | Filing | Aug 14, 2025 | — |
| 424B3 | Prospectus | Aug 14, 2025 | — |
| CORRESP | Letter to the SEC | Aug 12, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2025 | — |
| S-3 | Shelf registration | Aug 8, 2025 | — |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 8, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2025 | Jun 17, 2025 |
| 10-Q | Quarterly report | May 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 29, 2025 | Apr 29, 2025 |
| ARS | Annual report to shareholders | Apr 23, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 23, 2025 | Jun 17, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 27, 2025 | Mar 21, 2025 |
| 8-K | Current report | Mar 14, 2025 | Mar 12, 2025 |
| S-8 | Employee stock plan registration | Feb 25, 2025 | — |
| 10-K | Annual report | Feb 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Other events
|
Dec 13, 2024 | Dec 13, 2024 |
| 10-Q | Quarterly report | Oct 31, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Other events
|
Oct 23, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Other events
|
Sep 19, 2024 | Sep 14, 2024 |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Agreement ended
|
Jul 10, 2024 | Jul 9, 2024 |
| 8-K |
Current report
Other events
|
Jun 18, 2024 | Jun 18, 2024 |
| 424B7 | Filing | Jun 18, 2024 | — |
| D | Filing | Jun 12, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 23, 2024 | May 23, 2024 |
| F-6EF | Filing | May 16, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
May 16, 2024 | May 16, 2024 |
| 10-Q | Quarterly report | May 2, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| DEFA14A | Additional proxy material | Apr 18, 2024 | — |
| 8-K |
Current report
Material agreement, Officer or director change
|
Apr 18, 2024 | Apr 16, 2024 |
| ARS | Annual report to shareholders | Apr 15, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 15, 2024 | May 16, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 29, 2024 | Mar 29, 2024 |
| S-8 | Employee stock plan registration | Feb 20, 2024 | — |
| 10-K | Annual report | Feb 20, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Feb 20, 2024 | Feb 20, 2024 |
| 8-K |
Current report
Other events
|
Dec 14, 2023 | Dec 14, 2023 |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Other events
|
Sep 11, 2023 | Sep 11, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Jul 13, 2023 | Jul 12, 2023 |
| 424B5 | Prospectus supplement | Jul 13, 2023 | — |
| 424B5 | Prospectus supplement | Jul 12, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Jun 23, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Other events
|
May 26, 2023 | May 26, 2023 |
| 424B5 | Prospectus supplement | May 26, 2023 | — |
| S-3ASR | Automatic shelf registration | May 26, 2023 | — |
| 8-K |
Current report
Material agreement
|
May 10, 2023 | May 4, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 13, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 13, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Other events
|
Apr 3, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 28, 2023 | Mar 27, 2023 |
| S-8 | Employee stock plan registration | Feb 28, 2023 | — |
| 10-K | Annual report | Feb 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Other events
|
Feb 14, 2023 | Feb 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 23, 2023 | Jan 17, 2023 |
| 8-K |
Current report
Other events
|
Nov 8, 2022 | Nov 8, 2022 |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Other events
|
Sep 7, 2022 | Sep 7, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Material agreement
|
Jul 15, 2022 | Jul 15, 2022 |
| 8-K |
Current report
Other events
|
Jul 12, 2022 | Jul 12, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2022 | Jun 27, 2022 |
| 10-Q | Quarterly report | May 5, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
May 5, 2022 | May 5, 2022 |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 27, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2022 | Jun 27, 2022 |
| 8-K |
Current report
Other events
|
Apr 12, 2022 | Apr 11, 2022 |
| S-8 | Employee stock plan registration | Mar 1, 2022 | — |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Jan 5, 2022 | Jan 3, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 8, 2021 | Nov 8, 2021 |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Other events
|
Oct 26, 2021 | Oct 26, 2021 |
| 8-K |
Current report
Material agreement, Results of operations
|
Oct 14, 2021 | Oct 12, 2021 |
| 424B5 | Prospectus supplement | Oct 14, 2021 | — |
| 424B5 | Prospectus supplement | Oct 12, 2021 | — |
| S-3ASR | Automatic shelf registration | Oct 12, 2021 | — |
| 8-K |
Current report
Other events
|
Oct 7, 2021 | Oct 7, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 13, 2021 | Jul 9, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 28, 2021 | Jun 28, 2021 |
| DEFA14A | Additional proxy material | Jun 16, 2021 | — |
| DEFA14A | Additional proxy material | May 27, 2021 | — |
| 8-K |
Current report
Other events
|
May 24, 2021 | May 24, 2021 |
| 424B5 | Prospectus supplement | May 24, 2021 | — |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 28, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2021 | Jun 28, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 9, 2021 | Apr 7, 2021 |
| 8-K |
Current report
Other events
|
Apr 2, 2021 | Mar 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 19, 2021 | Mar 17, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 16, 2021 | Mar 16, 2021 |
| S-8 | Employee stock plan registration | Mar 11, 2021 | — |
| 10-K | Annual report | Mar 11, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2021 | Mar 11, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 14, 2021 | Jan 14, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 20, 2020 | Nov 20, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Other events
|
Oct 2, 2020 | Oct 2, 2020 |
| 424B5 | Prospectus supplement | Oct 2, 2020 | — |
| 8-K |
Current report
Material agreement, New debt
|
Oct 1, 2020 | Sep 30, 2020 |
| S-8 | Employee stock plan registration | Aug 5, 2020 | — |
| 10-Q | Quarterly report | Aug 5, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2020 | Aug 5, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2020 | Jun 29, 2020 |
| EFFECT | Filing | Jun 15, 2020 | — |
| CORRESP | Letter to the SEC | Jun 11, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2020 | — |
| S-3 | Shelf registration | Jun 5, 2020 | — |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| DEF 14A | Proxy statement | Apr 27, 2020 | Jun 29, 2020 |
| 8-K |
Current report
Other events
|
Apr 7, 2020 | Apr 7, 2020 |
| S-8 | Employee stock plan registration | Mar 10, 2020 | — |
| 10-K | Annual report | Mar 10, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2020 | Mar 10, 2020 |
| 8-K |
Current report
Other events
|
Feb 28, 2020 | Feb 18, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 25, 2020 | Feb 21, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2019 | Dec 17, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 20, 2019 | Nov 20, 2019 |
| 8-K |
Current report
Material agreement
|
Nov 12, 2019 | Nov 6, 2019 |
| 10-Q | Quarterly report | Nov 7, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2019 | Nov 7, 2019 |
| 8-K |
Current report
Officer or director change
|
Nov 5, 2019 | Oct 30, 2019 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2019 | Sep 26, 2019 |
| 8-K |
Current report
Other events
|
Sep 30, 2019 | Sep 28, 2019 |
| 10-Q | Quarterly report | Aug 8, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2019 | Aug 8, 2019 |
| 8-K |
Current report
Officer or director change
|
Jul 24, 2019 | Jul 18, 2019 |
| CT ORDER | Filing | May 24, 2019 | — |
| EFFECT | Filing | May 23, 2019 | — |
| S-8 | Employee stock plan registration | May 23, 2019 | — |
| 424B4 | Prospectus | May 23, 2019 | — |
| EFFECT | Filing | May 22, 2019 | — |
| F-6/A | Filing | May 22, 2019 | — |
| CERT | Filing | May 22, 2019 | — |
| CORRESP | Letter to the SEC | May 20, 2019 | — |
| CORRESP | Letter to the SEC | May 20, 2019 | — |
| 8-A12B | Filing | May 20, 2019 | — |
| CORRESP | Letter to the SEC | May 20, 2019 | — |
| UPLOAD | Letter from the SEC | May 16, 2019 | — |
| S-1/A | Amended registration statement | May 15, 2019 | — |
| F-6 | Filing | May 13, 2019 | — |
| CORRESP | Letter to the SEC | May 13, 2019 | — |
| S-1/A | Amended registration statement | May 13, 2019 | — |
| UPLOAD | Letter from the SEC | May 7, 2019 | — |
| CORRESP | Letter to the SEC | May 1, 2019 | — |
| CORRESP | Letter to the SEC | Apr 26, 2019 | — |
| S-1 | Registration statement | Apr 26, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2019 | — |
| DRSLTR | Filing | Mar 22, 2019 | — |
| DRS/A | Filing | Mar 22, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 12, 2019 | — |
| DRS | Filing | Dec 21, 2018 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BCYC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Cambridge, United Kingdom
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1761612
- Former names
- BICYCLE THERAPEUTICS Ltd (until May 24, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.